𝛼SK or Search

ENTITY

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (1349 HK)

139

Analysis

Health Care • China

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is primarily engaged in the innovative research and development, production, and marketing of biopharmaceuticals. The company offers a range of products including photodynamic technology drugs like aminolevulinic acid hydrochloride and hemoporfin, doxorubicin liposome under the Libord brand, genetic engineering drugs, and oral solid preparation technology drugs. It is headquartered in Zhangjiang Hi-Tech Park, Pudong, Shanghai, China, and was established in November 1996.

more

Refresh

Exchange Announcement • 12 Oct 2026 18:04

Discloseable Transaction-Subscription Of Structured Deposit Product Under The Ping An Bank

Exchange Announcement • 11 Oct 2026 18:11

Discloseable Transaction-Subscription Of Structured Deposit Product Under The Spd Bank

Exchange Announcement • 09 Oct 2026 17:08

Discloseable Transaction-Subscription Of Structured Deposit Product Under The Bank Of China

Exchange Announcement • 24 Sep 2026 17:31

Supplemental Announcement-In Relation To The Annual Report 2025

Exchange Announcement • 28 Aug 2026 17:01

Interim Report For The Six Months Ended 30 June 2026

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x